News

Vaccines and antibodies up for debate at CDC advisory panel meeting
The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...
Moderna, Inc. (MRNA): A Bull Case Theory
We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ ...
Factbox-Vaccines and antibodies up for debate at CDC advisory panel meeting
The meeting, scheduled for June 25-26, will review existing data and vote on RSV and influenza vaccines, along with ...
Stocktwits on MSN4d
Moderna, Pfizer, Novavax Draw Bearish Buzz Ahead Of CDC Panel With Vaccine Skeptics
Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...
pharmaphorum3d
Moderna banks on OpenAI to accelerate mRNA research
Moderna teams up with OpenAI, further integrating ChatGPT across its mRNA drug development and manufacturing operations. Skip to main content Friday 27 June 2025 . BlueSky linkedin youtube ...
pharmaphorum3d
Boost for mRNA as Moderna to acquire OriCiro for $85 million
Biotech Moderna, Inc. and OriCiro Genomics K.K. have announced they have entered into a definitive agreement for Moderna to acquire OriCiro at a cost of $85 million.. The deal marks 10-year-old ...
Nasdaq4d
Moderna, Inc. Common Stock (MRNA) - Nasdaq
Discover real-time Moderna, Inc. Common Stock (MRNA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.